Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 20

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 20
---
-9-

| • |     | the Board determines in good faith after consultation with its outside legal counsel and financial advisors that                                                  
 such Acquisition Proposal constitutes a Superior Offer and that failure to take such action would be inconsistent with its fiduciary duties under applicable law. |

As described under the caption “ The Merger Agreement—Termination Fees,” if STAAR terminates the Merger Agreement after the date of the Merger Agreement but prior to the adoption of the Merger Agreement by STAAR stockholders for the purpose of entering into an agreement in respect of a Superior Offer, STAAR must pay the STAAR Termination Fee (as defined in “ The Merger Agreement—Termination Fees”) to Alcon. The STAAR Termination Fee is equal to $43,425,000, which is reduced in the case of an acquiror that made an Acquisition Proposal which, before the expiration of the 45-daywindow shop period (which ends at 11:59 p.m., Eastern Time, on September 19, 2025), the Board determines constitutes or could reasonably be expected to lead to a Superior Offer. Additionally, at any time prior to receipt of the Stockholder Approval, other than in connection with an Acquisition Proposal, the Board may, in response to an Intervening Event (as defined in “ The Merger Agreement—Recommendation of the Board; Recommendation Change”) make a Recommendation Change if:

| • |     | the Board determines in good faith, after consultation with outside counsel and its financial advisor, that the 
 failure of the Board to take such action would be inconsistent with its fiduciary duties under applicable law;  |

| • |     | (i) at least four (4) business days before making such a Recommendation Change, STAAR provides Alcon a                                                                                                                                               
 written notice specifying the facts and circumstances for such potential Recommendation Change, and (ii) during such four (4)-business day period, if requested by Alcon, has negotiated in good faith with respect to any revisions to the terms of 
 the Merger Agreement or another proposal to the extent proposed by Alcon; and                                                                                                                                                                        |

| • |     | the Board determines in good faith after consultation with its outside legal counsel and financial advisors that                
 the failure to make the Recommendation Change would continue to be inconsistent with its fiduciary duties under applicable law. |

For more information, see “ The Merger Agreement—Recommendation of the Board; Recommendation Change.” Termination of the Merger Agreement Either STAAR or